Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Improving depression and enhancing resilience in family dementia caregivers: a pilot randomized placebo-controlled trial of escitalopram.

Lavretsky H, Siddarth P, Irwin MR.

Am J Geriatr Psychiatry. 2010 Feb;18(2):154-62. doi: 10.1097/JGP.0b013e3181beab1e.

2.

Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study.

Brown ES, Howard C, Khan DA, Carmody TJ.

Psychosomatics. 2012 Jan-Feb;53(1):75-80. doi: 10.1016/j.psym.2011.07.009.

PMID:
22221724
3.

Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.

Burke WJ, Gergel I, Bose A.

J Clin Psychiatry. 2002 Apr;63(4):331-6.

PMID:
12000207
4.

Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial.

Angermann CE, Gelbrich G, Störk S, Gunold H, Edelmann F, Wachter R, Schunkert H, Graf T, Kindermann I, Haass M, Blankenberg S, Pankuweit S, Prettin C, Gottwik M, Böhm M, Faller H, Deckert J, Ertl G; MOOD-HF Study Investigators and Committee Members.

JAMA. 2016 Jun 28;315(24):2683-93. doi: 10.1001/jama.2016.7635.

PMID:
27367876
5.

Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.

Stahl SM, Gergel I, Li D.

J Clin Psychiatry. 2003 Nov;64(11):1322-7.

PMID:
14658946
6.

Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2.

Flynn Longmire CV, Drye LT, Frangakis CE, Martin BK, Meinert CL, Mintzer JE, Munro CA, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG; DIADS-2 Research Group.

Am J Geriatr Psychiatry. 2014 Jan;22(1):14-24. doi: 10.1016/j.jagp.2013.02.014.

7.

Treatment of depression associated with age-related macular degeneration: a double-blind, randomized, controlled study.

Brody BL, Field LC, Roch-Levecq AC, Moutier CY, Edland SD, Brown SI.

Ann Clin Psychiatry. 2011 Nov;23(4):277-84.

PMID:
22073385
8.

Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care.

Lepola UM, Loft H, Reines EH.

Int Clin Psychopharmacol. 2003 Jul;18(4):211-7.

PMID:
12817155
9.

The Effect of Escitalopram on Mood and Cognition in Depressive Alzheimer's Disease Subjects.

An H, Choi B, Park KW, Kim DH, Yang DW, Hong CH, Kim SY, Han SH.

J Alzheimers Dis. 2017;55(2):727-735.

PMID:
27716660
10.

Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.

Schaefer M, Sarkar R, Knop V, Effenberger S, Friebe A, Heinze L, Spengler U, Schlaepfer T, Reimer J, Buggisch P, Ockenga J, Link R, Rentrop M, Weidenbach H, Fromm G, Lieb K, Baumert TF, Heinz A, Discher T, Neumann K, Zeuzem S, Berg T.

Ann Intern Med. 2012 Jul 17;157(2):94-103. doi: 10.7326/0003-4819-157-2-201207170-00006.

PMID:
22801672
11.

Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.

Pigott TA, Prakash A, Arnold LM, Aaronson ST, Mallinckrodt CH, Wohlreich MM.

Curr Med Res Opin. 2007 Jun;23(6):1303-18. Epub 2007 Apr 27.

PMID:
17559729
12.

The effect of escitalopram versus placebo on perceived stress and salivary cortisol in healthy first-degree relatives of patients with depression-A randomised trial.

Knorr U, Vinberg M, Gether U, Winkel P, Gluud C, Wetterslev J, Kessing LV.

Psychiatry Res. 2012 Dec 30;200(2-3):354-60. doi: 10.1016/j.psychres.2012.05.015. Epub 2012 Jun 14.

PMID:
22703642
13.

Complementary use of tai chi chih augments escitalopram treatment of geriatric depression: a randomized controlled trial.

Lavretsky H, Alstein LL, Olmstead RE, Ercoli LM, Riparetti-Brown M, Cyr NS, Irwin MR.

Am J Geriatr Psychiatry. 2011 Oct;19(10):839-50. doi: 10.1097/JGP.0b013e31820ee9ef.

14.

The effect of escitalopram on sleep problems in depressed patients.

Lader M, Andersen HF, Baekdal T.

Hum Psychopharmacol. 2005 Jul;20(5):349-54.

PMID:
15912558
15.

Enhancing the quality of life of dementia caregivers from different ethnic or racial groups: a randomized, controlled trial.

Belle SH, Burgio L, Burns R, Coon D, Czaja SJ, Gallagher-Thompson D, Gitlin LN, Klinger J, Koepke KM, Lee CC, Martindale-Adams J, Nichols L, Schulz R, Stahl S, Stevens A, Winter L, Zhang S; Resources for Enhancing Alzheimer's Caregiver Health (REACH) II Investigators.

Ann Intern Med. 2006 Nov 21;145(10):727-38.

16.

Prevention of depression with escitalopram in patients undergoing treatment for head and neck cancer: randomized, double-blind, placebo-controlled clinical trial.

Lydiatt WM, Bessette D, Schmid KK, Sayles H, Burke WJ.

JAMA Otolaryngol Head Neck Surg. 2013 Jul;139(7):678-86. doi: 10.1001/jamaoto.2013.3371.

PMID:
23788218
17.

Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer's disease.

Choe YM, Kim KW, Jhoo JH, Ryu SH, Seo EH, Sohn BK, Byun MS, Bak JH, Lee JM, Yun HJ, Han MI, Woo JI, Lee DY.

Int J Geriatr Psychiatry. 2016 Jul;31(7):731-9. doi: 10.1002/gps.4384. Epub 2015 Nov 9.

PMID:
26553313
18.

Escitalopram versus placebo in the treatment of dysthymic disorder.

Hellerstein DJ, Batchelder ST, Hyler S, Arnaout B, Toba C, Benga I, Gangure D.

Int Clin Psychopharmacol. 2010 May;25(3):143-8. doi: 10.1097/YIC.0b013e328333c35e.

PMID:
21811192
19.

Effect of Escitalopram vs Placebo Treatment for Depression on Long-term Cardiac Outcomes in Patients With Acute Coronary Syndrome: A Randomized Clinical Trial.

Kim JM, Stewart R, Lee YS, Lee HJ, Kim MC, Kim JW, Kang HJ, Bae KY, Kim SW, Shin IS, Hong YJ, Kim JH, Ahn Y, Jeong MH, Yoon JS.

JAMA. 2018 Jul 24;320(4):350-358. doi: 10.1001/jama.2018.9422. Erratum in: JAMA. 2018 Nov 27;320(20):2154.

PMID:
30043065
20.

Efficacy of escitalopram in patients with severe depression: a pooled analysis.

Llorca PM, Azorin JM, Despiegel N, Verpillat P.

Int J Clin Pract. 2005 Mar;59(3):268-75.

PMID:
15857321

Supplemental Content

Support Center